Sven Zumhagen1,2, Eva Maria Zeidler3, Birgit Stallmeyer4, Marko Ernsting4, Lars Eckardt2, Eric Schulze-Bahr4,5. 1. Department of Cardiovascular Medicine, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Albert-Schweitzer-Campus 1, Gebäude D3, D-48149 Münster, Germany sven.zumhagen@ukmuenster.de. 2. Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany. 3. Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4. Department of Cardiovascular Medicine, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Albert-Schweitzer-Campus 1, Gebäude D3, D-48149 Münster, Germany. 5. Interdisciplinary Centre for Clinical Research (IZKF), University Hospital Münster, Münster, Germany.
Abstract
AIMS: Brugada syndrome (BrS) is characterized by a typical electrocardiogram (ECG) pattern in right precordial leads (V1-V3; so-called type 1 ECG) and an increased risk of sudden cardiac death due to ventricular fibrillation. Annual cardiac event rates vary from 0.5% in asymptomatic to 7.7% in high-risk patients. So far, spontaneous occurrence of the type 1 ECG, survived cardiac arrest, and/or documented ventricular arrhythmias are main risk predictors, whereas other factors (e.g. family history or genotype) are not applicable for risk stratification. In this study, we investigated the relationship between Tpeak-Tend intervals (TpTe) as a novel ECG parameter for the occurrence of cardiac arrhythmias. METHODS AND RESULTS: Clinical and genetic data of 78 unrelated BrS patients (male: n = 57, age: 45 ± 14 years) were retrospectively analysed for medical history, gene mutation, and ECG parameters (in particular heart rate, PQ, QRS, QT, and TpTe) as obtained after digital measurements. TpTe in ECG lead V1 (87 ± 30 vs. 71 ± 27 ms; P = 0.017) and the TpTe/QT ratio (0.24 vs. 0.19; P = 0.018) were significantly higher in high-risk BrS patients than in other BrS patients. In the other right precordial leads typically indicative for BrS, no significant difference was noted. CONCLUSION: Assessment of the TpTe interval or the TpTe/QT ratio in lead V1 is potentially useful as a non-invasive risk marker for BrS patients with life-threatening arrhythmias. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Brugada syndrome (BrS) is characterized by a typical electrocardiogram (ECG) pattern in right precordial leads (V1-V3; so-called type 1 ECG) and an increased risk of sudden cardiac death due to ventricular fibrillation. Annual cardiac event rates vary from 0.5% in asymptomatic to 7.7% in high-risk patients. So far, spontaneous occurrence of the type 1 ECG, survived cardiac arrest, and/or documented ventricular arrhythmias are main risk predictors, whereas other factors (e.g. family history or genotype) are not applicable for risk stratification. In this study, we investigated the relationship between Tpeak-Tend intervals (TpTe) as a novel ECG parameter for the occurrence of cardiac arrhythmias. METHODS AND RESULTS: Clinical and genetic data of 78 unrelated BrS patients (male: n = 57, age: 45 ± 14 years) were retrospectively analysed for medical history, gene mutation, and ECG parameters (in particular heart rate, PQ, QRS, QT, and TpTe) as obtained after digital measurements. TpTe in ECG lead V1 (87 ± 30 vs. 71 ± 27 ms; P = 0.017) and the TpTe/QT ratio (0.24 vs. 0.19; P = 0.018) were significantly higher in high-risk BrS patients than in other BrS patients. In the other right precordial leads typically indicative for BrS, no significant difference was noted. CONCLUSION: Assessment of the TpTe interval or the TpTe/QT ratio in lead V1 is potentially useful as a non-invasive risk marker for BrS patients with life-threatening arrhythmias. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Marta Pérez-Hernández; Marcos Matamoros; Silvia Alfayate; Paloma Nieto-Marín; Raquel G Utrilla; David Tinaquero; Raquel de Andrés; Teresa Crespo; Daniela Ponce-Balbuena; B Cicero Willis; Eric N Jiménez-Vazquez; Guadalupe Guerrero-Serna; Andre M da Rocha; Katherine Campbell; Todd J Herron; F Javier Díez-Guerra; Juan Tamargo; José Jalife; Ricardo Caballero; Eva Delpón Journal: JCI Insight Date: 2018-09-20
Authors: Cao Thach Tran; Tania Atanasovska; Claus Graff; Jacob Melgaard; Jørgen K Kanters; Robert Smith; Aaron C Petersen; Keld P Kjeldsen; Michael J McKenna Journal: Eur J Appl Physiol Date: 2022-01-20 Impact factor: 3.078
Authors: Dimitrios Asvestas; Gary Tse; Adrian Baranchuk; George Bazoukis; Tong Liu; Athanasios Saplaouras; Panagiotis Korantzopoulos; Christina Goga; Michael Efremidis; Antonios Sideris; Konstantinos P Letsas Journal: Int J Cardiol Heart Vasc Date: 2018-03-08
Authors: Gary Tse; Mengqi Gong; Christien Ka Hou Li; Keith Sai Kit Leung; Stamatis Georgopoulos; George Bazoukis; Konstantinos P Letsas; Abhishek C Sawant; Giacomo Mugnai; Martin C S Wong; Gan Xin Yan; Pedro Brugada; Gian-Battista Chierchia; Carlo de Asmundis; Adrian Baranchuk; Tong Liu Journal: J Arrhythm Date: 2018-09-10